반응식
[CH3:1][O:2][C:3]1[C:8]2[N:9]=[C:10]([NH2:12])[S:11][C:7]=2[C:6]([CH:13]2[CH2:18][CH2:17][O:16][CH2:15][CH2:14]2)=[CH:5][CH:4]=1.Cl[C:20](OC1C=CC=CC=1)=[O:21].[CH:29]12[CH2:36][CH2:35][CH:32]([CH2:33][CH2:34]1)[CH2:31][NH:30]2>>[CH3:1][O:2][C:3]1[C:8]2[N:9]=[C:10]([NH:12][C:20]([N:30]3[CH2:31][CH:32]4[CH2:35][CH2:36][CH:29]3[CH2:34][CH2:33]4)=[O:21])[S:11][C:7]=2[C:6]([CH:13]2[CH2:18][CH2:17][O:16][CH2:15][CH2:14]2)=[CH:5][CH:4]=1참가 물질
4
실험 절차
Using 4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-ylamine, phenyl chloroformate and 2-aza-bicyclo[2.2.2]octane, the title compound was prepared as off-white crystals (53% yield). MS: m/e=402(M+H+), mp 237-239° C.
출처 및 근거
- ORD 기록
- ord-0de5a3b0151c44e7b1a777f62343ef92
- 출처 데이터셋
- uspto-grants-2008_05
- 특허 번호
- US07371748B2
연결된 노트
불러오는 중…